Skip to main content
OpenTrials

Clinical trial condition

Non Small Cell Lung Cancer

Explore clinical trials studying Non Small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

654 public trials 176 recruiting studies
Refine in advanced search Browse all conditions

Non Small Cell Lung Cancer trial results

Completed

Radiofrequency Ablation of Pulmonary Tumors Response Evaluation

NCT00690703

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • University of New South Wales Sydney, Australia
  • University Hospital Essen Essen, Germany
  • Ludwig-Maximilians University München, Germany
View Trial Details
Completed

Metronomic Oral Vinorelbine in Patients With Metastatic Tumors

NCT00278070

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +22 more
Locations
  • Henry Dunant Hospital Athens, Greece
  • Sotiria Hospital Athens, Greece
  • University Hospital "Attikon" Athens, Greece
  • Agii Anargiri Cancer Hospital Athens, Greece
View Trial Details
Active, Not Recruiting

Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study

NCT04258137

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +22 more
Locations
  • Centre hospitalier de la Côte Basque Bayonne, France
  • Clinique Tivoli-Ducos Bordeaux, France
  • Institut Bergonie Bordeaux, France
  • Polyclinique Bordeaux Nord Aquitaine Bordeaux, France
View Trial Details
Active, Not Recruiting

Lobectomy-First vs. Lymphadenectomy-First for Operable NSCLC (LOFTY)

NCT06577792

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • Fujian Provincial Hospital Fuzhou, Fujian, China
  • Gansu Provincial Hospital Lanzhou, Gansu, China
View all 26 locations
View Trial Details
Active, Not Recruiting

Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors

NCT05887492

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +16 more
Locations
  • UCLA Hematology/Oncology Santa Monica, California, United States
  • SCRI at HealthOne Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 13 locations
View Trial Details

Related conditions